March, 2009Digoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand)
Audience: Pharmacists, cardiology healthcare professionals, consumers [Posted 04/01/2009] Caraco Pharmaceutical Laboratories and FDA notified healthcare professionals of a consumer-level recall of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin,…
Judge Freezes Assets of Madoff’s Sons, Wife, Brother, and Top Executives
The wife, sons, brother, and top executives of convicted Wall Street scam artist Bernard Madoff have had their financial assets frozen by a Connecticut judge.
Continue →Plavix-Aspirin Combo May Prevent Strokes and Heart Attacks; Increased Bleeding Risk Also Noted
Taking the popular blood thinner Plavix in combination with aspirin appears to better prevent strokes and heart attacks in people who are at increased risk of the cardiac problems due to a particular heartbeat abnormality, new research shows. Plavix is the blockbuster Bristol-Myers Squibb and Sanofi-Aventis drug that has been linked to an increased risk of ulcers and gastrointestinal bleeding. However, the new scientific findings indicate the drug could be of use in treating millions of people in the United …
Continue →Digoxin Heart Failure Pills Recalled Over Possible Overdose Risks
Generic heart failure and irregular heartbeat pills have been recalled due to concerns they may differ in size and contain more or less the proper dose of digoxin, the active ingredient. The drug maker, Caraco Pharmaceutical Laboratories, Ltd., is recalling Caracao brand Digoxin USP in 0.125 mg tablets and Digoxin USP in 0.25 mg tablets. The pills were distributed before March 31, 2009 and set to expire in September 2011. The Food and Drug Administration is assisting in the voluntary …
Continue →FDA Warns Companies to Stop Making Unapproved Pain Killers
The U.S. Food and Drug Administration is warning companies to stop manufacturing and distributing unapproved narcotic drugs, which are sold in various forms and are widely used to treat pain. The FDA has sent warning letters to nine manufacturers of 14 unapproved drugs, ordering them to stop circulating the products. The banned narcotic products include items containing high concentrate morphine sulfate oral solutions and immediate release tablets containing morphine sulfate, hydromorphone or oxycodone. Companies which received the FDA warning letters …
Continue →1 Million Pounds of Pistachios Recalled Due to Possible Salmonella Contamination
Move over peanuts, make way for pistachios. About one million pounds of pistachios processed by a California company and sold nationwide since September 2008 have been recalled due to concerns that the nuts may be contaminated with salmonella bacteria, the Food and Drug Administration said. Several illnesses have been reported and may be caused by salmonella, a common type of food poisoning that can cause severe and deadly infections in the elderly, young children, and people who are ill or …
Continue →Supreme Court Upholds $79.5 Million Punitive Award Against Philip Morris
Tobacco giant Philip Morris must pay more than $79.5 million in punitive damages to the widow of a longtime Oregon smoker, the U.S. Supreme Court has ruled.
Continue →120,000 Yamaha Rhino ATVs Recalled After Scores of Driver-Passenger Deaths
About 120,000 Yamaha Rhinos are being recalled after federal product safety officials received dozens of reports of deaths and injuries to people driving or riding in two models of the popular but accident-prone off-road vehicles.
Continue →New Drug for Advanced Kidney Cancer Drug Earns FDA Approval
Some patients with advanced kidney cancer that has worsened after receiving other, more traditional cancer treatments now have a new option for treatment. The U.S. Food and Drug Administration has approved Afinitor (generic everolimus) for the treatment of renal cell cancer, the most common type of kidney cancer. Renal cell cancer begins in the lining of the small tubules in the kidney that filter waste products from the blood. The devastating form of cancer is resistant to radiation therapy, chemotherapy, …
Continue →New Type 2 Diabetes Drug Doesn’t Cause Same Heart Problems as Others, FDA Says
A new Type 2 diabetes drug being developed by Bristol-Myers Squibb does not appear to cause the same deadly heart-related problems as other diabetes drug, according to the Food and Drug Administration. The drug, Onglyza, uses a chemical reaction to reduce blood sugar and is similar to Januvia, the blockbuster drug by Merk. As diabetes rates continued to rise – 23 million adult and teenaged Americans now have the condition — more and more companies are rolling out new drugs …
Continue →Recent Related Features
All Stories
facebook
rss
twitter